demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
clarithromycine Rashad ...

1 studies excluded by filtering options 0

6691 Tsiakos, 2020 1313not a RCThigh risk of bias